ANDA 85878, held by Watson Labs. Imipramine Hydrochloride.
As of Nov 16, 2026, ANDA 85878 (Imipramine Hydrochloride), held by Watson Labs, was first approved by FDA on Oct 16, 1978, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 16, 1978 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Imipramine Hydrochloride25MG ยท tablet;oral | Imipramine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters